← Community Healthcare Trust Inc (CHCT) — catalysts, pipeline & price
Catalyst Dossier · compiled by CeliA 🧫
Community Healthcare Trust Inc (CHCT)
Real Estate Investment Trusts · market cap $498M
Research and calibrated estimates, not financial advice — verify before acting.
Next catalyst
None scheduled
Pipeline
7
programs
Upcoming events
0
next 90d+
Dossier
Not yet
generate it
The catalyst path
No upcoming catalysts in our calendar.
Pipeline
| Asset | Phase | Indication |
|---|---|---|
| Epinephrine | Phase 3 | Gastric Neoplasm |
| Regorafenib | Phase 3 | Gastro-Oesophageal Cancer |
| QUARTET LDQT | Phase 2 | Hypertension |
| Fluoride varnish | Phase 3 | Dental Caries |
| Hydroxychloroquine | Phase 2 | SARS-CoV 2 |
| Albendazole | Phase 3 | Helminthiasis |
| Enalapril Folic Acid Tablets Combined With amlodipine | Phase 3 | Hypertension |
Price & technical context
3-month
+13.6%
6-month
+13.1%
12-month
+5.9%
52-wk range
$13.31–$18.14
vs 50-day MA
+3.5%
vs 200-day MA
+11.0%
Realized vol
26.2%
Max drawdown
-51.6%
Daily closes through 2026-06-24. Realized vol annualized; max drawdown over ~2 years.
The full dossier is a Pro feature
Thesis, bull & bear, the if-approved scenario, financials, smart-money signals and risks — compiled by CeliA. The catalyst path & pipeline above are free.
Sources & data
- SEC filings — EDGAR filings for CHCT (10-K, 10-Q, S-3, 13D/G, Form 4)
- Clinical trials — 7 registered trials on ClinicalTrials.gov (per-trial NCT links in the pipeline)
- Market & financial data — SEC EDGAR (XBRL filings, Form 4), Yahoo Finance, Nasdaq — prices, statements, key metrics, insider & institutional filings.
- Regulatory — openFDA, FDA advisory & PDUFA calendars.
Approval odds use historical phase base rates; the if-approved scenario is illustrative (see its note). Figures trace to the sources above — verify before acting.
Data from CatalystAlert (ClinicalTrials.gov, SEC EDGAR, openFDA, market-data providers). Compiled by CeliA. Not financial advice.